# FDA Recalls Xanax XR Batch Due to Effectiveness Concerns
The FDA has issued a recall for a specific batch of Xanax XR (extended-release alprazolam) over concerns that the medication may not work as intended. Xanax XR treats anxiety and panic disorders, and patients who take this medication rely on consistent dosing throughout the day.
The recall affects a limited batch number of the medication. Extended-release formulations are designed to release medication slowly over time, maintaining steady levels in the body. When these tablets fail to dissolve properly or release their active ingredient as designed, patients may experience breakthrough anxiety or panic symptoms.
Parents of teenagers or young adults who take Xanax XR should check their prescription bottles immediately. The recall notice includes specific batch numbers and expiration dates. If your child's medication matches the recalled batch, contact your pharmacy or healthcare provider before stopping the medication.
Abruptly discontinuing benzodiazepines like alprazolam can cause rebound anxiety or withdrawal symptoms. Your child's doctor needs to provide guidance on whether to switch to an alternative medication or obtain a different batch from the same manufacturer.
This situation underscores the importance of verifying medication recalls, especially for psychiatric medications where consistency matters. The FDA maintains a searchable database of current recalls on its website. Parents can also sign up for recall alerts through the FDA's notification system.
If your child experiences increased anxiety or panic symptoms after taking medication from this batch, contact their prescribing physician immediately. Report any concerning symptoms to the FDA's MedWatch program as well, which helps the agency identify additional safety issues.
Keep all medication bottles in their original packaging with labels intact. This makes it easier to identify recalled batches quickly if announcements occur.